Protein Restoration Shows Promise for Premature Infant Lung Repair
UCLA-led research has identified a molecular switch to regenerate blood vessels in premature infants' lungs, addressing bronchopulmonary dysplasia (BPD). Restoring a healthy NTRK2 protein isoform in mouse models and organoids improved lung repair, offering a potential future treatment. This preclinical breakthrough could significantly impact neonatal care globally.
- UCLA-led team discovered a molecular switch for lung blood vessel regeneration.
- In BPD, a nonfunctional NTRK2 protein isoform hinders vascular repair.
- mRNA therapy restored healthy NTRK2, boosting blood vessel growth in models.
- Treatment reversed lung damage in mouse models of bronchopulmonary dysplasia.
- Findings published in Cell Stem Cell, corroborated by Cincinnati Children's.
- Preclinical study aims for future human infant clinical testing.
Read the full story on Quick Digest.